At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Jakub Hort, MD, PhD, from University in Prague, Czech Republic, reviews new approaches for the development of disease-modifying therapies, including biomarker selection approaches and improved experimental models, for the treatment of patients with Alzheimer’s disease.
